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Abstract The aim of this study was the characterization of the
human GL4 subunit of heterotrimeric G proteins. Human GL4 is
widely expressed. Its gene is located on chromosome 3 with a
genomic structure indistinguishable from that of the genes of
GL1 to GL3, but entirely di¡erent from GL5. In vitro trans-
lation co-precipitation analyses revealed that GL4 can form
stable dimers with GQ1, GQ2, GQ3, GQ4, GQ5, GQ7, GQ10,
GQ11, GQ12, and GQ13, dimers which were also able to stimulate
phospholipase L2.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Heterotrimeric G proteins, which are composed of GK, GL
and GQ subunits, are key components for signal transduction
from an activated heptahelical receptor to e¡ector systems
including enzymes (e.g. adenylyl cyclases, phospholipases C
(PLC)), adapter proteins and ion channels (for review [1]).
The GK subunit is a GTPase that interacts in the GDP-bound
state with GLQ dimers. In the human genome 16 genes for GK,
¢ve genes for GL, and 12 genes for GQ subunits have been
identi¢ed [2]. The proteins encoded by these genes give rise to
the formation of more than 1000 di¡erent G protein hetero-
trimers and may thus determine receptor and e¡ector speci-
¢city [1]. However, available evidence suggests that not all
theoretically possible heterotrimers do exist or are of func-
tional relevance in vivo [3]. The ¢ve known GL isoforms
can be divided into the subfamily of GL1^GL4 proteins which
share high homology (V80^90%) and the GL5/GL5L protein
which is only V50% homologous to the other GL proteins
and which exhibits distinct biochemical properties [4]. All GL
subunits belong to the superfamily of propeller proteins and
are made up of seven regular WD domains (referring to a
recurrent Trp-Asp motif among others) which form a toroid-
like structure [5]. At the N-terminus an K-helical extension of
20 amino acids forms a coiled-coil domain [5]. Each of the
WD domains is composed of four anti-parallel L-sheets, which
are referred to as a^d, with the a strand located in the center
of the tunnel and the d strand at the outside surface of the
protein [5]. Beside the WD motif at the end of strand c, there
is a highly conserved aspartate in the loop connecting strands
b and c and a glycine-histidine motif following the d strand
[5].
GL1 and GL2, which were cloned ¢rst, and GL5, which
di¡ers considerably from the other GL proteins, have been
intensively characterized [1^3]. GL3 and its splice variant
GL3s have attracted considerable pathophysiological and
pharmacogenetic interest [6,7]. However, information on the
biochemical and pharmacological properties of GL4 is scarce.
Recently, the cDNA of the human GL4 subunit has been
published and its properties have been analyzed with special
focus on the activation of N-type Ca2þ channels [9]. Here, we
report an in-depth analysis of the GL4 gene (GNB4) structure;
we also determined the dimerization of GL4 with di¡erent GQ
subunits and their ability to activate PLCL2.
2. Materials and methods
RNA, prepared from di¡erent tissues using the RNAeasy kit (Qia-
gen, Hilden, Germany), was in vitro transcribed as detailed [10]. Hu-
man, rat, and mouse GL4 cDNAs were ampli¢ed by reverse tran-
scription polymerase chain reaction (RT-PCR) using Pfu polymerase
(Promega, Madison, WI, USA). Amplicons were A-tailed, cloned into
the pGEM-T easy vector (Promega) and sequenced. The same proce-
dure was used to clone and sequence the various GQ subunits (except
GQ2, GQ3, GQ5, GQ7 and GL1 which were kind gifts of Dr. Lohse,
Wu«rzburg, Germany). All G protein subunits used were subcloned
into the pcDNA3.1þ expression vector (Invitrogen). For control pur-
poses, transcripts of GK16, a G protein con¢ned to hematopoietic
cells, was ampli¢ed by RT-PCR with oligonucleotide primers encom-
passing the entire open reading frame (for sequences see the Table in
the Supplementary material in the Web version).
For analysis of the exon^intron boundaries genomic DNA was
puri¢ed from whole blood using the QiAMP blood kit and exons
were ampli¢ed using primers located in the adjacent introns and se-
quenced.
To study GL/GQ interactions co-precipitation analyses were per-
formed with in vitro translated hemagglutinin (HA)-tagged GQ sub-
units as devised by E. Neer [11]. GQ subunits were tagged at the
N-terminus with the HA epitope by PCR using the above generated
vectors as templates with modi¢ed sense primers carrying the se-
quence for the HA epitope, an improved Kozak sequence and suitable
restriction sites. The resulting PCR amplicons were ligated into
pcDNA3.1þ vector and sequenced. The primer sequences for all
PCRs are detailed in the Table in the Supplementary material in the
Web version.
GL and HA-GQ subunits were in vitro translated with the TNT
quick-coupled transcription/translation system (Promega) driven by
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the T7 promoter of the pcDNA3.1þ vector. In brief, 1 Wg vector DNA
was mixed with 40 Wl reticulocyte lysate and 0.8 MBq [35S]L-methio-
nine (Hartmann Analytic, Braunschweig, Germany), adjusted to a
total of 50 Wl with H2O and incubated at 30‡C for 90 min. Aliquots
of all in vitro translated GL and GQ subunits were separated by so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and the translation e⁄cacy was determined by phosphoimag-
ing. In vitro translation mix of each HA-tagged GQ (15 to 32 Wl,
depending on the translation e⁄cacy) was mixed with 20 Wl of in vitro
translated GL1 or GL4 and incubated for 90 min at 37‡C. Subse-
quently, 20 Wl protein A agarose (Santa Cruz Biotechnologies, Heidel-
berg, Germany) was added to these reaction mixes and pelleted by
centrifugation. The supernatants were transferred into new reaction
tubes and 10 Wl (4 Wg) of a monoclonal anti-HA antibody (clone
12CA5, Roche Mannheim) was added and incubated for 90 min at
4‡C under constant shaking. Thereafter, 40 Wl of protein A agarose
was added and incubated for 60 min at 4‡C. The reaction mixes were
centrifuged, the supernatants were removed and the agarose pellets
washed four times in 500 Wl ice-cold RIPA bu¡er. Finally, the agarose
pellets were washed in 400 Wl ice-cold 50 mM Tris^HCl bu¡er (pH
7.5), resuspended in 70 Wl of a modi¢ed SDS sample bu¡er (use of
m-cresol as dye to allow for separation of GQ subunits), incubated at
95‡C for 5 min and separated on 15% SDS^PAGE. Gels were vac-
uum-dried, exposed to phospho-screens and the radioactive bands
were visualized with a PhosphoImager.
Activation of PLCL2 by GLQ subunits was studied essentially as
described [12]. The PLCL2 clone was a kind gift of Dr. M.I. Simon,
Pasadena, CA, USA. It was subcloned into the pcDNA3.1þ vector.
COS-7 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) containing 10% fetal calf serum, 100 U/ml penicillin and
100 Wg/ml streptomycin (Invitrogen). 6U104 cells were plated onto
each well of a 24 well cell culture dish. After 24 h cells were trans-
fected using the E¡ectene transfection reagent (Qiagen) according to
the manufacturer’s instructions. Onto each well 0.07 Wg vector DNA
was applied containing equal amounts of PLCL2, GL and GQ (non-
modi¢ed wild-type) vector. In controls without PLCL2 or G protein
subunits the total amount of transfected DNA was kept constant by
addition of empty pcDNA3.1þ vector DNA. The next day, cells were
labelled with 0.5 ml inositol-free DMEM containing 3.5 WCi myo-
[3H]inositol for another 24 h. Thereafter, the label medium was re-
moved and the cells were incubated in 0.5 ml inositol-free DMEM
containing 10 mM LiCl for 1 h at 37‡C. Cells were lysed and water-
soluble inositol phosphates were separated by anion exchange chro-
matography as described [12]. COS-7 cells transfected with GQ sub-
units but no GL subunits served as controls and GLQ-mediated stim-
ulation of PLCL2 was de¢ned as the percent ratio of water-soluble
inositol phosphates produced in the presence of overexpressed GLQs
versus the inositol phosphates formed in cells overexpressing the re-
spective GQ. All experiments were performed in triplicate and the
results shown in Fig. 4 are meansRS.E.M. from three or four inde-
pendent experiments. GLQ-mediated activation of PLCL2 was as-
sumed if this ratio exceeded the 100% value (Student’s t-test;
P6 0.05). Expression of the transfected GL subunits was veri¢ed by
Western blot analysis using a anti-GL1 and anti-GL4 antibodies ac-
cording to the supplier’s instructions (Santa Cruz Biotechnology, anti-
bodies sc-379 and sc-382). Likewise, expression of HA-GQ subunits
upon transfection was controlled with the anti-HA antibody.
3. Results and discussion
Based on the published mouse GL4 sequence we performed
BLAST analyses in public data bases and identi¢ed the EST
clone AK001890 from human placenta as a potential human
GL4 clone. Using oligonucleotide primers derived from this
sequence and starting with RNA from human B lymphoblasts
and brain tissues we ampli¢ed the cDNA of the GL4 open
reading frame and short adjacent 5P- and 3P-untranslated se-
quences (Fig. 1). The sequences from four independent clones
con¢rmed the sequence of the EST clone (AK001890) and
were identical to the one published recently (AF300648 [9]).
However, in two independent GL4 cDNA clones from di¡er-
ent individuals we identi¢ed single nucleotide polymorphisms
Fig. 1. Nucleotide and amino acid sequence of human GL4. Under-
scored is the N-terminal coiled-coil region. Arrows refer to the
L-strands of the WD domains (numbered in lower case). Conserved
motifs of WD domains (GH, WD motifs, aspartate between strands
c and d) are marked in gray. The exons of GL4 are alternately indi-
cated in gray and black in the cDNA sequence.
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Fig. 2. GL4 transcript expression in di¡erent tissues of man, mouse, and rat demonstrated by RT-PCR. A control RT-PCR was performed to
demonstrate GK16 transcripts. In contrast to GL4, GK16 transcripts were con¢ned to hematopoietic cells only, indicating that our RT-PCR con-
ditions are suitable to demonstrate di¡erential transcript expression.
Fig. 3. Genomic organization of GL proteins. A: Exons are indicated by boxes, the open reading frame is shown in black. ‘ATG’ refers to the
start codon. Hatched bars refer to alternatively spliced exons observed in GL3 and GL5. Schematic drawing, intron lengths not to scale.
B: Schematic drawing of the seven-blade propeller structure of GL proteins according to [5]. Arrows indicate L-sheets. Exons are represented
alternately by black solid and gray hatched boxes and black solid and gray interrupted lines.
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(SNPs). One SNP involved a C117T exchange (number refers
to the translation start codon ATG=1) another a T186C ex-
change. Both SNPs do not a¡ect the amino acid composition
of the human GL4 and their biological signi¢cance ^ if any ^
remains to be determined.
In parallel, we generated a mouse GL4 clone which exhib-
ited several nucleotide exchanges compared to the original
GL4 sequence (M87286). Two variations resulted in amino
acid exchanges (D132N; A140P; Figure in the Supplementary
material in the Web version). We veri¢ed our sequence in
independent clones and we obtained a rat GL4 clone. All of
these GL4 clones have a proline at position 140 and an aspar-
agine at position 132. The latter is located in the loop between
strands c and d at the outer face of the protein and it is highly
conserved in GL1^GL3 [5]. It is tempting to speculate that the
weak biological activities observed with the M87286 clone are
caused by these probable sequence errors [13,14].
The human GL4 protein shares the highest homologies with
GL1 and GL2. The amino acid and nucleotide sequences of
the human GL4 and an annotation of its structural elements
derived from the comparison with the crystallized GL1 [5] are
shown in Fig. 1. Two groups have analyzed the expression of
mouse [8] and human [9] GL4 by RT-PCR and obtained di-
verging results. Whereas von Weizsa«cker reported a ubiqui-
tous expression of GL4 with high levels in brain, heart and
spleen, Ruiz-Velasco observed a more restricted GL4 expres-
sion with low levels of GL4 transcripts in brain, heart and
spleen. Our data, obtained from human, rat and mouse tissues
and cultured cells, favor a wide if not ubiquitous tissue dis-
tribution (Fig. 2). A de¢nite con¢rmation by Western blot
analysis is needed.
Next, we performed genomic BLAST analyses and identi-
¢ed the clone NT005950 as a potential genomic clone of GL4.
Based on this sequence we designed oligonucleotide primers
adjacent to the putative exons, ampli¢ed them, and deter-
mined the genomic structure. The GNB4 gene is located on
chromosome 3 and consists of 10 exons and nine introns (Fig.
1). We have previously characterized human GNB3 [15], and
the genomic sequences of human GNB1, GNB2, and GNB5
are obtainable by BLAST analyses in the human genome
project database (AL109917, AC009488 and AC010674).
With the exception of the 5P- and 3P-non-translated regions,
GL1^GL4 exhibit an identical genomic organization (Fig. 3).
GL5, the least homologous GL subunit (V53%), has a com-
pletely di¡erent genomic structure. This is in accordance with
the notion that GL1^GL4 and GL5 belong to di¡erent ancient
GL families [2]. In Fig. 3B the genomic organizations of the
GL1^GL4 proteins and the GL5 protein are superimposed on
their presumed three-dimensional structures as derived from
crystallization studies [5]. Of note, there is no close correlation
between exon structures and protein motifs, e.g. WD domains
or propeller blades. Again, the totally di¡erent genomic orga-
nization of GL5 is evident.
Next, we focused on the biochemical properties of GL4 and
investigated its ability to dimerize with GQ proteins. Available
evidence suggests that GLQ dimers (except GL5) are stable
upon dimerization and that GLQ diversity may determine re-
ceptor and e¡ector speci¢city [1,3]. With GL2 and GL3 not all
theoretically possible GLQ dimers are formed [3]. Several as-
says exist to test for GLQ association. One possibility is to
investigate the activation of GLQ-dependent e¡ector systems
upon overexpression of GLQ subunits. However, if the e¡ector
Fig. 4. Co-precipitation assays of in vitro translated GL and GQ
subunits. GL1, GL4 and HA-GQs were in vitro translated separately,
mixed and after formation of the GLQ dimer immunoprecipitated.
Control experiments (bottom) show that a GL precipitate is ob-
served only in the presence of HA-GQ.
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system is not activated, it is impossible to di¡erentiate absent
GLQ dimerization from failure of the respective dimer to acti-
vate the e¡ector. Therefore, we performed co-precipitation
assays as described [11]. GLs and HA-tagged GQs were in vitro
translated separately in the presence of [35S]methionine.
Thereafter, labelled GLs and GQs were mixed and incubated.
In the presence of reticulocyte lysate which contains chaper-
onins, GLs fold correctly, interact with GQs and can dimerize
[3,11]. These dimers can then be precipitated with an anti-HA
antibody. Co-precipitation of a GL with a HA-GQ indicates
their mutual interaction. Here, we analyzed the interaction of
GL4 ^ and as a control GL1 ^ with all known mammalian GQ
proteins except the highly specialized GQolf . As shown in Fig.
4 (bottom), GL1, GL4 and wild-type GQs were not recognized
by the anti-HA antibody. Precipitation of a GL protein was
only observed in the presence of a HA-modi¢ed GQ subunit.
Our data indicate that both GL1 and GL4 form dimers with
all known GQ proteins although the interactions with GQ1 and
GQ11 were quantitatively weaker. By yeast two-hybrid screen
Yan et al. analyzed dimerization of some GLQs [16]. In their
assay, GL4 interacted with the tested GQ2, GQ3, GQ4, GQ5, and
GQ7, but not with GQ1 [16], which was also the weakest inter-
action in our experiments.
Next, we investigated whether these GLQ dimers activate a
GLQ-dependent e¡ector system, in this case PLCL2. Despite
comparable protein levels upon transfection of GL1 and GL4,
as determined by Western blot analysis (Fig. 5C, upper two
panels), dimers with GL4 were generally weaker in activating
PLCL2 than dimers with GL1. Overexpression of most GLQ
dimers resulted in a signi¢cant although sometimes modest
(e.g. GL4Q2, GL4Q5, GL4Q10, GL4Q12) activation of PLCL2.
However, the dimers GL1Q11 and GL4Q8c did not stimulate
PLCL2, although the respective GL and GQ subunits could
easily be detected by Western blotting (Fig. 5C, lower two
panels). These results are interesting since the dimers
GL4Q8c and GL1Q11 could be co-precipitated in the in vitro
translation assays and may indicate GLQ speci¢city to activate
PLCL2. On the other hand, GL1Q1, GL4Q1 and GL4Q11, for
which weaker interactions were observed in the co-precipita-
tion assays, did activate PLCL2. The most active GL4Q dimer
to stimulate PLCL2 was GL4Q4. Similarly, GL4Q4 was found
to be most e¡ective in inhibiting N-type Ca2þ channels and
activating GIRK potassium channels [9,17]. Beside GL4Q4
these latter studies examined only GL4Q2 and GL4Q3, which
were also biologically active.
Taken together, our data show that the human GL4 is
widely expressed and is able to dimerize with almost all GQ
subunits. Available evidence suggests that GL4 modulates im-
portant e¡ector systems, i.e. N-type Ca2þ channels, GIRK
potassium channels and phospholipase isoforms.
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Fig. 5. Activation of PLCL2 by GL1Q and GL4Q. PLCL2 and the re-
spective GLs and GQs were transfected into COS-7 cells and the
GLQ-mediated activation of PLCL2 was quanti¢ed. MeansRS.E.M.
from at least three di¡erent experiments for GL1 (A) and GL4 (B)
with measurements made in triplicate. Results were normalized for
the activation of PLCL2 upon expression of GQ only. C: Upper two
panels: Western blot analyses demonstrating similar expression lev-
els of GL1 and GL4 with each of the investigated GQ subunits.
Lower two panels: Western blot analyses for di¡erent HA-GQ sub-
units expressed in the presence of GL1 or GL4. The results indicate
that the absent PLCL2 stimulation by GL1Q11 and GL4Q8c is not at-
tributable to an altered expression of the respective GQ subunits.
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